Epic Sciences gathers $52M for blood tests that match cancer patients to therapies | FierceBiotech
Sep 20, 2018 @ 12:35

Cancer blood test company Epic Sciences brought in $52 million to advance its suite of liquid biopsies, which use computer vision and machine learning to identify circulating tumor cells while characterizing the body’s immune response at the same time, toward regulatory approval.

Sourced through Scoop.it from: www.fiercebiotech.com

Leave a Reply